TissueLabs

TissueLabs is a private, Zurich-based company developing and commercializing a comprehensive biofabrication platform centered on 3D bioprinting systems and specialized biomaterials. Originating from an ambitious internal project to create a bioartificial heart, the company pivoted to democratize its enabling technologies for the global research community. It operates as a platform tools company, selling hardware, consumables, and kits to accelerate R&D in biomedical science, positioning itself in the early-revenue stage of the growing tissue engineering market.

Integrated biofabrication platform ('Tissueverse') combining advanced 3D bioprinting systems for precise cell deposition and a proprietary library of tissue-specific biomaterials designed to mimic the extracellular matrix of 15+ human tissues.

TissueLabs competes in the 3D bioprinting and biomaterials market against established players like CELLINK (now part of BICO), Allevi, and Regemat 3D, as well as numerous academic spinoffs. Its key differentiators are its focus on tissue-specific biomaterials for 15+ tissues and its stated 'open platform' approach to community-driven innovation.